Ontology highlight
ABSTRACT: Importance
Thresholds for initiating statin therapy should be informed by patients' preferences.Objective
To define the preference distribution for statin therapy across the spectrum of cardiovascular disease (CVD) risk after participants were informed about the benefits and harms of statin therapy.Design, setting, and participants
A cross-sectional survey was conducted from May 13 to June 2, 2020. Participants included 304 individuals aged 40 to 75 years drawn from a nonprobability opt-in panel who had not taken a statin or proprotein convertase subtilisin/kexin type 9 inhibitor in the past 3 years and knew the results of their total cholesterol, high-density lipoprotein cholesterol, and blood pressure measurements.Exposures
Personalized 10-year CVD risk wi
SUBMITTER: Brodney S
PROVIDER: S-EPMC7961307 | biostudies-literature | 2021 Mar
REPOSITORIES: biostudies-literature